Infopathy
All

Retinoic acid

16.3 k
Immersion Health
Membership required
How to use it?
Start transfer
Primary Application
Imprint
For what
Blood and Cardiovascular
Immune and Lymphatic
Integumentary
Mitochondrial and Energy Production
Source
Allopathy
For whom
People

All Trans Retinoic Acid (ATRA) is FDA approved in the treatment of promyelocytic leukemia. ATRA is a strong differentiating agent. As such, ATRA has potential as a therapy in a number of cancers, especially in the context of IC medicines. ATRA binds to retinoic acid receptors, and subsequently activates DNA transcription activity to move immature (e.g. malignant) cells toward normal maturation. Consider the use of ATRA in cases of cancer and precancerous lesions, including polyps, actinic keratosis, and others.

Comments
Experiences

Retinoic acid
Replies
Mar 18, 2026
Is retinoic acid applicable only to myeloid leukemia? Can it be applied to all types of leukemia?
Show original
Liked
0
1 reply
Hide branch
Mar 18, 2026
Hello. During hospital tests, my white blood cell, platelet, and red blood cell counts dropped significantly, so I was admitted to a negative pressure ward. I am undergoing a bone marrow biopsy tomorrow, and they said that about 20% of the cells are immature and it appears to be acute leukemia. Please let me know of any methods that can help with treatment, whether in conjunction with hospital therapy or... See more
Show original
Liked
0
1 reply
Hide branch
Dec 02, 2025
Is this for topical use on skin keratosis?
Liked
0
1 reply
Hide branch
 Show modal
We use cookies to ensure you get the best experience on our site. Learn more
OK
Show modal